U.S. markets closed
  • S&P 500

    -1.14 (-0.03%)
  • Dow 30

    +152.97 (+0.45%)
  • Nasdaq

    -58.96 (-0.52%)
  • Russell 2000

    +5.67 (+0.30%)
  • Crude Oil

    -1.66 (-2.13%)
  • Gold

    +8.40 (+0.48%)
  • Silver

    +0.06 (+0.29%)

    -0.0008 (-0.07%)
  • 10-Yr Bond

    -0.0150 (-0.40%)

    -0.0023 (-0.19%)

    +0.5100 (+0.37%)

    -41.22 (-0.25%)
  • CMC Crypto 200

    +4.32 (+1.13%)
  • FTSE 100

    +20.07 (+0.27%)
  • Nikkei 225

    -100.06 (-0.35%)

Stocks moving after hours: Big Bank stocks, Meta, MindMed

Yahoo Finance's Seana Smith breaks down major stock moves after the closing bell.

Video Transcript

SEANA SMITH: All right, Dave, a couple of big names here. Let's start with what we're seeing from the big banks. Goldman Sachs, Citi, Bank of America, Morgan Stanley among 16 firms that have reached an agreement with the SEC. They're going to pay regulators $1.1 billion in penalties for failing to monitor employees' use of unauthorized messaging apps.

And we know it has been a tough go at it for some of the big banks, at least over the past month, in this rising rate environment. Also, fears of an economic slowdown. You can see Goldman Sachs off just around 13% in the past month. Citi down just over 14%. Bank of America off about 10%, and Morgan Stanley, the best of the bunch over the past month, off just around 8 and 1/2%.

All right, let's take a look at Meta because it was Sheryl Sandberg's last day at headquarters. She got a sendoff from a number of her employees, thanking her for the job that she has done for the company over the last several years. She announced back on June 1 that she was stepping down as COO. It has certainly been a rough year for Meta, as the company transitions its focus to the Metaverse. Year to date, taking a look at that stock, off just around 60% today, right around 52-week lows at 134.40.

Let's round it out with MindMed, a huge performer here-- or underperformer, I should say-- in after hours. Some news here announcing a proposed public offering of common shares, offering those subject to market conditions. We're seeing that stock tank after hours. And of course, just taking a look at a year to date chart, it's been a rough go at it for this company, off just around 70%. But even in just the last three months, we have seen this biopharma company under a tremendous amount of pressure, off just around 43%.